维力医疗(603309.SH)：2025年三季报净利润为1.92亿元

Core Insights - The company reported a total revenue of 1.191 billion yuan for Q3 2025, with a net profit attributable to shareholders of 192 million yuan [1] - The operating cash flow showed a net inflow of 160 million yuan [1] - The asset-liability ratio increased to 33.03%, up by 0.69 percentage points compared to the same period last year [1] Financial Performance - The latest gross profit margin is 44.18%, which is a decrease of 0.86 percentage points from the previous quarter and a decrease of 0.62 percentage points from the same period last year [1] - The return on equity (ROE) stands at 9.90% [1] - The diluted earnings per share (EPS) is 0.65 yuan [1] Operational Efficiency - The total asset turnover ratio is 0.41 times [1] - The inventory turnover ratio is 3.65 times [1] Shareholder Structure - The number of shareholders is 18,900, with the top ten shareholders holding a total of 165 million shares, accounting for 56.31% of the total share capital [1] - The largest shareholder is Gao Bo Investment (Hong Kong) Limited, holding 31.4 million shares [1] - Other significant shareholders include Guangzhou Songwei Enterprise Management Consulting Co., Ltd. and Guangzhou Weiyue Trade Consulting Co., Ltd. with holdings of 13.3 million and 5.35 million shares respectively [1]